Armenia-US Collaboration to Address Chronic Disease via Education in Social Determinants Science (ACCESS)
亚美尼亚与美国合作通过社会决定因素科学教育解决慢性病问题 (ACCESS)
基本信息
- 批准号:10664096
- 负责人:
- 金额:$ 24.44万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-04-01 至 2028-02-29
- 项目状态:未结题
- 来源:
- 关键词:AddressAlcohol consumptionAlcoholismAmericanArmeniaAwarenessCOVID-19 pandemicCause of DeathCessation of lifeChronic DiseaseClinicalCollaborationsCommunitiesCountryDiseaseDisease OutcomeDisparityDoctor&aposs DegreeEducationFaceFutureGoalsHealthHealth PrioritiesHealthcareInequalityInfrastructureInstitutionMentorsObesityOverweightPlayPoliciesPrevalenceProgram SustainabilityPublic HealthResearchResearch InfrastructureResearch PersonnelResearch TrainingRisk FactorsRoleScienceSmokingSocial EnvironmentStudentsTobaccoTrainingTraining ProgramsUnhealthy DietUnited States National Institutes of HealthUniversitiesWashingtonburden of illnessdisabilitydisorder controldisorder preventiondisorder riskhealth disparityknowledge translationlow and middle-income countriesmaleprematureprogramsresearch data disseminationresponseskillssocial determinants
项目摘要
SUMMARY/ABSTRACT
The COVID-19 pandemic heightened awareness of health disparities and related social determinants (SDs)
globally, as well as inequalities in countries’ capacities to study and address such disparities and their SDs.
This is especially relevant to non-communicable diseases (NCDs), which account for >70% of deaths annually
and disproportionately impact low- and middle-income countries (LMICs). Armenia (AM) faces particular NCD-
related challenges; NCDs account for 93% of all deaths and the top 10 causes of death, premature death, and
disability. Critical to decreasing NCD burden is reducing modifiable NCD risk factors (e.g., tobacco/alcohol use,
unhealthy diet); this is particularly important in AM. AM has the 11th highest male smoking rate globally (52%),
ranks in the top 40% of countries in alcoholism rates, and has a 48% prevalence of overweight/obesity. SDs
(e.g., healthcare, social context) impact both modifiable NCD risk factors and NCD outcomes, and play a
crucial role in NCD-related health disparities in AM. We propose the Armenia-US Collaboration to Address
Chronic Disease via Education in Social Determinants Science (ACCESS) program, in response to PAR-
21-230. Its overall goal is to reduce the NCD burden in AM by enhancing research capacity related to NCD
prevention and control, emphasizing SDs of NCD risk factors as key components. ACCESS is a strategic
collaboration between George Washington University (GW) and American University of Armenia (AUA),
alongside AM’s Ministry of Health (MOH) and its entities (e.g., NIH). Leveraging our team’s substantial ongoing
collaborations, ACCESS will be an effective, sustainable program that enhances research infrastructure,
training, and research opportunities related to NCD prevention and control for junior researchers. In Aim 1, we
will develop a formal NCD prevention and control research training program (emphasizing SDs of NCD risk
factors) and related institutional infrastructure. We will offer specialized training to: a) long-term MPH trainees
who already hold an MD or related doctoral degree in order to develop future NCD research leaders; and b)
short-term trainees (e.g., public health/clinical students/professionals) to enhance core NCD research skills. In
Aim 2, we will advance AM’s national NCD research agenda via mentored research focused on SDs of NCD
risk factors among future NCD research leaders (i.e., long-term trainees). In Aim 3, we will catalyze NCD-
related research dissemination and knowledge translation to inform policy and practice, by enhancing related
skills and leveraging the engagement of the MOH and its entities. ACCESS will be the 1st program of its kind in
AM and will address AM’s national health priorities. We will establish future NCD prevention and control
leaders and an educational core for the broader community of public health and clinical professionals in AM.
Our team is uniquely-suited to establish ACCESS, enhance NCD research capacity in AM in the next 5 years,
and sustain and expand it in scope and scale in the long-term to optimize its impact on global NCD burden.
摘要/摘要
19009年大流行提高了对健康差异和相关社会决定者(SDS)的认识
在全球范围内,以及国家研究和解决此类差异及其SD的能力的不平等。
这与非通信疾病(NCD)特别相关,该疾病占每年死亡的70%
并不成比例地影响低收入和中等收入国家(LMIC)。亚美尼亚(AM)面对特定的NCD-
相关挑战; NCDS占所有死亡人数的93%,死亡,过早死亡以及
残疾。对于减少NCD伯嫩至关重要的是减少可修改的NCD危险因素(例如,烟草/酒精,
不健康的饮食);这在AM中尤为重要。 AM在全球占据男性吸烟率为11(52%),
在酒精中毒率中排名前40%的国家,超重/肥胖症患病率为48%。 SDS
(例如,医疗保健,社会环境)影响可修改的NCD风险因素和NCD结果,并发挥
AM中与NCD相关的健康差异的关键作用。我们提出了亚美尼亚 - 美国的合作来解决
通过社会决定因素科学教育(访问)计划的慢性病,以应对
21-230。它的总体目标是通过增强与NCD相关的研究能力来减少AM中的NCD Burnen
预防和控制,强调NCD风险因素的SDS作为关键组成部分。访问是一种策略
乔治华盛顿大学(GW)和美国亚美尼亚大学(AUA)之间的合作,
与AM卫生部(MOH)及其实体(例如NIH)一起。利用我们团队的实质性持续
协作,访问将是一个有效,可持续的计划,可增强研究基础架构,
培训以及与NCD预防和控制人员有关的研究机会。在AIM 1中,我们
将制定正式的NCD预防和控制研究培训计划(强调NCD风险的SDS
因素)和相关的机构基础设施。我们将提供专门的培训:a)长期MPH学员
他们已经拥有医学硕士或相关的博士学位,以培养未来的NCD研究领导者;和b)
短期学员(例如,公共卫生/临床学生/专业人员),以提高核心NCD研究技能。在
AIM 2,我们将通过针对NCD的SD的指导研究来推进AM的国家NCD研究议程
未来NCD研究领导者(即长期学员)的危险因素。在AIM 3中,我们将催化NCD-
相关研究的传播和知识翻译以通过增强相关的方式为政策和实践提供信息
技能和利用卫生部及其实体的参与。访问将是同类中的第一个程序
AM并将解决AM的国家健康重点。我们将建立未来的NCD预防和控制
领导者和AM公共卫生和临床专业人士更广泛的社区的教育核心。
我们的团队非常适合建立访问权限,在未来5年内提高AM的NCD研究能力,
长期以来维持和扩展其范围和规模,以优化其对全球NCD负担的影响。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Carla J Berg其他文献
Types and Brands of Derived Psychoactive Cannabis Products: An Online Retail Assessment, 2023.
精神活性大麻衍生产品的类型和品牌:在线零售评估,2023 年。
- DOI:
- 发表时间:
2024 - 期刊:
- 影响因子:3.8
- 作者:
M. Rossheim;Kayla K Tillett;Viktor. Vasilev;C. LoParco;Carla J Berg;P. Trangenstein;R. Yockey;Steven Y Sussman;Michael B. Siegel;David H. Jernigan - 通讯作者:
David H. Jernigan
Derived psychoactive cannabis products and 4/20 specials: An assessment of popular brands and retail price discounts in Fort Worth, Texas, 2023.
衍生精神活性大麻产品和 4/20 特价商品:对 2023 年德克萨斯州沃斯堡流行品牌和零售价格折扣的评估。
- DOI:
10.1016/j.drugalcdep.2024.111119 - 发表时间:
2024 - 期刊:
- 影响因子:4.2
- 作者:
M. Rossheim;C. LoParco;Carla J Berg;Kayla K. Tillett;P. Trangenstein;Doug Henry;R. Yockey;M. D. Livingston;David H. Jernigan;Steven Y. Sussman - 通讯作者:
Steven Y. Sussman
Carla J Berg的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Carla J Berg', 18)}}的其他基金
Effects of State Preemption of Local Tobacco Control Legislation on Disparities in Tobacco Use, Exposure and Retail
国家抢先实施地方烟草控制立法对烟草使用、接触和零售差异的影响
- 批准号:
10681733 - 财政年份:2023
- 资助金额:
$ 24.44万 - 项目类别:
Implementing a Scalable Smoke-free Home Intervention in Armenia and Georgia
在亚美尼亚和格鲁吉亚实施可扩展的无烟家庭干预措施
- 批准号:
10607033 - 财政年份:2023
- 资助金额:
$ 24.44万 - 项目类别:
Recreational Marijuana Marketing and Young Adult Consumer Behavior
休闲大麻营销和年轻成人消费者行为
- 批准号:
10597218 - 财政年份:2022
- 资助金额:
$ 24.44万 - 项目类别:
Recreational Marijuana Marketing and Young Adult Consumer Behavior - Administrative Supplement
休闲大麻营销和年轻成人消费者行为 - 行政补充
- 批准号:
10848546 - 财政年份:2022
- 资助金额:
$ 24.44万 - 项目类别:
Emory-Georgia Clean Air Research & Education (CARE) Program
埃默里-佐治亚州清洁空气研究
- 批准号:
10017980 - 财政年份:2019
- 资助金额:
$ 24.44万 - 项目类别:
Regulatory Impact on Vape Shops and Young Adults' Use of ENDS
监管对电子烟商店和年轻人使用 ENDS 的影响
- 批准号:
10310412 - 财政年份:2019
- 资助金额:
$ 24.44万 - 项目类别:
Assessing IQOS Marketing Influences and Consumer Behavior in Israel: Implications for the US
评估 IQOS 在以色列的营销影响和消费者行为:对美国的影响
- 批准号:
10246189 - 财政年份:2019
- 资助金额:
$ 24.44万 - 项目类别:
Regulatory Impact on Vape Shops and Young Adults' Use of ENDS
监管对电子烟商店和年轻人使用 ENDS 的影响
- 批准号:
10524237 - 财政年份:2019
- 资助金额:
$ 24.44万 - 项目类别:
Assessing IQOS Marketing Influences and Consumer Behavior in Israel: Implications for the US
评估 IQOS 在以色列的营销影响和消费者行为:对美国的影响
- 批准号:
10020369 - 财政年份:2019
- 资助金额:
$ 24.44万 - 项目类别:
Smoke-free Air Coalitions in Georgia and Armenia: A Community Randomized Trial
格鲁吉亚和亚美尼亚的无烟空气联盟:社区随机试验
- 批准号:
9372431 - 财政年份:2017
- 资助金额:
$ 24.44万 - 项目类别:
相似国自然基金
饮酒刺激肝细胞分泌外泌体对股骨头内H型血管的影响及分子机制
- 批准号:82272508
- 批准年份:2022
- 资助金额:52 万元
- 项目类别:面上项目
不同饮酒模式下CD11b+Ly6Chigh细胞群的分化及其对酒精性肝损伤的调控机制研究
- 批准号:
- 批准年份:2022
- 资助金额:30 万元
- 项目类别:青年科学基金项目
不同饮酒模式下CD11b+Ly6Chigh细胞群的分化及其对酒精性肝损伤的调控机制研究
- 批准号:82200656
- 批准年份:2022
- 资助金额:30.00 万元
- 项目类别:青年科学基金项目
定量设定法定最低饮酒年龄的方法研究
- 批准号:82103950
- 批准年份:2021
- 资助金额:24.00 万元
- 项目类别:青年科学基金项目
伏隔核多巴胺信号通过调节D1R-、D2R-MSNs活动影响个体差异饮酒行为的机制研究
- 批准号:
- 批准年份:2021
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
Identification of Prospective Predictors of Alcohol Initiation During Early Adolescence
青春期早期饮酒的前瞻性预测因素的鉴定
- 批准号:
10823917 - 财政年份:2024
- 资助金额:
$ 24.44万 - 项目类别:
Developing and Evaluating a Positive Valence Treatment for Alcohol Use Disorder with Anxiety or Depression
开发和评估治疗伴有焦虑或抑郁的酒精使用障碍的正价疗法
- 批准号:
10596013 - 财政年份:2023
- 资助金额:
$ 24.44万 - 项目类别:
BEASTS-Novel Biomimetic Liver Platform for Enabling ALD Researchers
BEASTS-为 ALD 研究人员提供支持的新型仿生肝脏平台
- 批准号:
10697452 - 财政年份:2023
- 资助金额:
$ 24.44万 - 项目类别:
Identifying the Effects of Race-Related Stressors on Laboratory- Induced Stress and Craving among African Americans with Alcohol Use Disorder
确定种族相关压力源对患有酒精使用障碍的非裔美国人实验室诱发的压力和渴望的影响
- 批准号:
10664454 - 财政年份:2023
- 资助金额:
$ 24.44万 - 项目类别: